Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 3:16 pm Purchase | 13G | Rain Oncology Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,937,801 9.99% | 105,148 (+5.74%) | View |
| 2022-02-14 3:13 pm Purchase | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 3,565,901 7.23% | 974,987 (+37.63%) | View |
| 2021-05-18 4:08 pm Purchase | 13G | Edgewise Therapeutics, Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,590,914 5.26% | 2,590,914 (New Position) | View |
| 2021-05-07 4:01 pm Purchase | 13G | Rain Oncology Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,832,653 9.99% | 1,832,653 (New Position) | View |
| 2021-04-30 4:25 pm Purchase | 13D | Biomea Fusion, Inc. BMEA | Cormorant Global Healthcare Master Fund LP | 3,172,478 11.03% | 3,172,478 (New Position) | View |